Company Profile

Aptus Pharmaceuticals Inc
Profile last edited on: 10/5/2007      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2001
First Award
2003
Latest Award
2003
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 Orchard Ridge Drive Suite 1e
Gaithersburg, MD 20878
   (240) 683-4500
   N/A
   www.aptuspharma.com
Location: Single
Congr. District: 06
County: Montgomery

Public Profile

Aptus is a drug discovery company that uses its proprietary technologies to develop therapeutics targeting G-Protein Coupled Receptors (GPCRs). Its leading technology is AptuScreen, a highly sensitive, cost-effective, homogeneous assay that directly measures cyclic AMP (cAMP) formation resulting from ligand-receptor binding. Aptus is using AptuScreen in its own drug discovery efforts as well as licensing rights to use of the technology to pharmaceutical and biotechnology companies

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2003 2 NIH $374,375
Project Title: Novel Melanocortin Receptor 4 Agonist for Obesity

Key People / Management

  Kevin Chance -- President

  Krystyna Belendiuk -- Former President

Company News

There are no news available.